Starin (Sertraline)

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Starin (Sertraline)

Quick Facts

Property Description
Active ingredient Sertraline Hydrochloride
Form Tablets, Capsules, Oral Concentrate
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulating mood and anxiety states
Origin Synthetic (Small Molecule)

Starin (Sertraline): Identity and Pharmacological Class

The medication Starin is a specific prescription-only brand name for the pharmaceutical compound with the active ingredient Sertraline Hydrochloride. This substance is formally classified as a member of the Selective Serotonin Reuptake Inhibitor (SSRI) pharmacological class, a category clinically recognized for its focused action on brain chemistry. Sertraline is a synthetic small molecule compound, chemically defined by its structure, which sets it apart from older agents like tricyclic antidepressants. The active component is formulated consistently across various forms.

Composition, Available Forms, and General Therapeutic Purpose

Sertraline is supplied for oral administration in multiple primary dosage forms, specifically film-coated tablets, capsules, and an oral concentrate liquid solution. This variety in forms allows for flexibility in managing patient needs. The core composition consists of the Sertraline Hydrochloride active ingredient combined with pharmaceutical excipients that define its final physical structure. The general therapeutic purpose of Sertraline is to act as a potent serotonin uptake inhibitor. This focused action on the serotonergic system helps to stabilize emotional equilibrium and is typically utilized in therapeutic plans requiring sustained support for persistent mood disruption and heightened anxiety states.

Regulatory References

  1. NIH StatPearls Sertraline
Advertisements

What side effects are possible with Starin (Sertraline)?

The official safety profile for Starin (Sertraline) outlines potential adverse reactions categorized by frequency and the body system affected, based on regulatory documentation.

Frequency-Classified Adverse Reactions

Adverse reactions are classified according to their incidence in clinical trials:

Classification Examples (Organ Systems Affected)
Very Common (ge 1/10) Nausea, Dry mouth, Insomnia, Dizziness, Headache, Diarrhea, Somnolence, Fatigue, Ejaculation failure (in men).
Common (ge 1/100 to <1/10) Vomiting, Indigestion (Dyspepsia), Palpitations, Anxiety, Decreased libido, Increased Sweating, Tremor.

Serious Adverse Reactions and Safety Constraints

The regulatory labels highlight specific, critical risks. These include the potential for Serotonin Syndrome, a serious condition involving changes in mental status and neuromuscular issues. There is also a documented risk of Suicidal Thoughts and Behaviors, particularly at the start of treatment or following dose adjustments in pediatric and young adult patients.

Official documents note that use is contraindicated with concurrent administration of Monoamine Oxidase Inhibitors (MAOIs). For Older Adults, there is a noted increased risk for Hyponatremia (low sodium levels), and caution is advised for individuals with Hepatic Impairment due to reduced clearance. The risk of Abnormal Bleeding is also documented.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

Documented Overdose Presentations and Severe Outcomes

Overexposure to Starin (Sertraline) is officially associated with documented clinical manifestations that frequently include somnolence, agitation, tremor, tachycardia (rapid heart rate), nausea, and vomiting. These signs affect the Central Nervous System, cardiovascular system, and gastrointestinal tract. Severe outcomes explicitly reported in regulatory labeling include the development of Serotonin Syndrome, seizures, coma (less frequent), and alterations in cardiac function such as ECG changes. Fatal outcomes have been reported, primarily in cases involving the co-ingestion of other drugs or alcohol, a factor officially noted as increasing the severity of the overdosage. Caution is also noted for patients with hepatic impairment.

Mandatory Emergency Action and Management

Regulatory authorities mandate that immediate medical attention must be sought for any suspected overdosage. The overdosage must be medically treated aggressively by healthcare professionals. As there is no specific antidote known for Sertraline, treatment is restricted to symptomatic and supportive measures. These measures include establishing and maintaining an airway, ensuring adequate oxygenation, and continuous monitoring of cardiac rhythm and vital signs. Procedures to limit systemic absorption, such as administering activated charcoal or gastric lavage, may be considered by treating staff.

Connection to the Overall Overdose Profile

The official overdose profile defines the range of documented clinical presentations and severe, potentially fatal outcomes, emphasizing the risk associated with the co-ingestion of other substances. Regulatory bodies strictly mandate that immediate professional medical help must be sought for any suspected overexposure, as management is entirely based on supportive measures and continuous monitoring.

Advertisements

Therapeutic Uses of Starin (Sertraline)

Starin (Sertraline) is generally used to provide symptomatic relief and supportive management across several domains characterized by symptoms related to heightened physiological activity and emotional distress. The medication is applied in clinical settings marked by the temporary or persistent discomfort associated with these symptom patterns.

This therapeutic support is relevant for managing conditions that include Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, Post-Traumatic Stress Disorder (PTSD), and Obsessive-Compulsive Disorder (OCD). The medication is used when groups of symptoms, like uncontrollable worry, persistent sadness, and unwanted intrusive thoughts, appear suddenly or fluctuate.

“Starin is applied across domains where additional symptomatic support is needed to help patients cope more steadily with difficult episodes.”

This assistance contributes to comfort during periods of heightened symptoms, and may assist with maintaining functional stability during these phases of heightened discomfort, which is particularly relevant during episodes of cyclical mood changes (PMDD) or following a significant stressful event. It contributes to easing the overall symptom load.

Quick Fact: Relief for Key Symptom Clusters
Starin is commonly used to help with symptoms that create noticeable interference with daily stability, supporting general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Starin (Sertraline)

Official regulatory information strictly defines the patient groups eligible for Starin (Sertraline) and those who are formally excluded.

Eligibility Classification Regulatory Rule
Absolute Contraindications Use is prohibited in patients with known hypersensitivity to sertraline or who are currently taking Monoamine Oxidase Inhibitors (MAOIs) or Pimozide. Use is also contraindicated in severe hepatic impairment.
Age-Related Use Use is established for adults (18 years and older). Pediatric use (6–17 years) is restricted to Obsessive-Compulsive Disorder (OCD) only. Use in children under 6 years is not established.
Conditional Use Patients with a history of mania/hypomania or controlled epilepsy require cautious use. The oral concentrate solution is prohibited for use by pregnant or potentially pregnant patients due to its alcohol content.
Organ Function Severe hepatic impairment is an absolute contraindication. For mild to moderate hepatic impairment, cautious use with a reduced dose is required. Renal impairment (mild to severe) does not require dose adjustment.
Advertisements

What should I know about interactions with other medicines?

The official regulatory documents for Starin (Sertraline) outline specific interaction patterns, constraints, and prohibited combinations. Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including irreversible types and the reversible MAOI Linezolid, is strictly contraindicated due to the serious risk of Serotonin Syndrome. A mandatory washout period of at least 14 days is required when switching from an irreversible MAOI to Sertraline, and at least 7 days when switching in the reverse direction.

Co-administration with Pimozide is also contraindicated due to documented increases in Pimozide exposure. Additionally, the Sertraline Oral Solution formulation is contraindicated with Disulfiram due to its alcohol content.

Sertraline is documented as an inhibitor of the CYP2D6 enzyme. This pharmacokinetic interaction can reduce the clearance and increase the plasma concentration of co-administered drugs metabolized by this pathway, necessitating caution. Other substances, such as Cimetidine, are documented to substantially decrease Sertraline clearance, leading to increased Sertraline exposure.

Pharmacodynamic interactions involve an increased risk of complications. Concomitant use with other serotonergic agents (e.g., Triptans, Tramadol) can potentiate the risk of Serotonin Syndrome. Co-administration with agents affecting hemostasis, such as NSAIDs, Aspirin, or Warfarin, is associated with an increased risk of bleeding. Furthermore, the herbal product St. John's Wort and alcohol are officially advised to be avoided or are not recommended during treatment. For patients with hepatic impairment, Sertraline clearance is reduced, which significantly increases Sertraline exposure.

Advertisements

Mechanism of Action

How Starin (Sertraline) Works — Mechanism of Action

Starin (Sertraline) functions as a Selective Serotonin Reuptake Inhibitor (SSRI) by binding to the serotonin transporter (SERT) protein on the presynaptic neuronal membrane. This interaction inhibits the reabsorption of the neurotransmitter serotonin (5-HT) from the synaptic cleft into the neuron. This molecular mechanism results in an increased concentration and prolonged presence of 5-HT at the postsynaptic receptors, initiating a heightened signal across the central serotonergic system.

The chronic elevation of synaptic 5-HT concentration triggers time-dependent adaptive alterations in pathway activity, including the gradual modulation and downregulation of specific 5-HT autoreceptors over several weeks. This delayed systemic adjustment induces neuronal and receptor adaptation, modulating central processes governing affective state, circadian rhythm, and executive function. Furthermore, this prolonged serotonergic signaling engages mechanisms that modulate neural plasticity and potentially neurogenesis in brain regions like the hippocampus. This structural consequence alters synaptic connectivity and neuronal excitability, shaping the long-term systemic effect of the mechanism.

Advertisements

Dosage and Administration Information

How to Use Starin (Sertraline): Administration Guidelines

Starin (sertraline) is administered orally once daily, and the tablets may be taken with or without food. The standard treatment protocol involves initial low dosing followed by gradual, controlled adjustments.


Standard Dosing and Titration

For most adult applications, the starting dose is 50 mg once daily, though treatment for Panic Disorder, Post-Traumatic Stress Disorder (PTSD), and Social Anxiety Disorder (SAD) typically begins at 25 mg. Dosage increases are usually implemented in 25 mg or 50 mg increments at intervals of no less than one week. The maximum recommended daily dose for these indications is 200 mg. Steady-state plasma levels are generally reached after approximately one week of consistent once-daily dosing.

Indication (in Adults) Initial Daily Dose Maximum Daily Dose
MDD, OCD 50 mg 200 mg
PD, PTSD, SAD 25 mg 200 mg

Form-Specific Instructions

When using the oral concentrate solution (20 mg/mL), the prescribed dose must be measured and immediately diluted by mixing it into 4 ounces of liquid, such as water, ginger ale, lemon-lime soda, lemonade, or orange juice. The concentrate should not be mixed with any other liquids. If a dose is missed, the standard approach is to skip the missed dose and resume the regular schedule at the next designated time, rather than taking a double dose.

Population-Specific Adjustments

In pediatric patients (ages 6–17) for Obsessive-Compulsive Disorder (OCD), the initial dose is 25 mg (ages 6–12) or 50 mg (ages 13–17), with a maximum daily dose of 200 mg. For patients with mild hepatic impairment, a half-dose is generally recommended for the starting and maximum dosage. Dose adjustment is typically not required for patients with renal impairment.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Sertraline is a Selective Serotonin Reuptake Inhibitor (SSRI) indicated for the management of conditions including Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and various anxiety disorders.

Efficacy and Symptom Trajectory

Recent randomized controlled trials have explored the effect of sertraline in primary care settings, including individuals with mild to moderate symptoms. Findings suggest that the drug's effect may be measurable as early as two weeks after administration, with anxiety symptoms and mental health-related quality of life showing early changes.

  • Depressive Symptoms: The effect on core depressive symptoms, such as low mood, has been reported to become more apparent over longer durations, typically beyond six weeks and up to 12 weeks of continuous use.
  • Anxiety Outcomes: Studies have noted a reduction in generalized anxiety symptoms, which often predates significant changes in core depressive symptoms.

Safety and Tolerability Profile

Sertraline is generally characterized by a favorable tolerability profile compared to older classes of antidepressants, such as tricyclic antidepressants (TCAs).

System Frequently Reported Adverse Events
Gastrointestinal Nausea, diarrhea, dry mouth, decreased appetite
Central Nervous System Insomnia, dizziness, somnolence, fatigue
Sexual Function Ejaculation failure, decreased libido

Serious warnings and precautions, relevant to all SSRIs, include the potential for Serotonin Syndrome when co-administered with other serotonergic agents, and an increased risk of bleeding, particularly when used alongside nonsteroidal anti-inflammatory drugs (NSAIDs) or anticoagulants. Patients under 25 are also subject to cautionary monitoring for suicidal thoughts and behaviors during initial treatment.

Key Studies & References

  1. NICE Guideline NG222: Depression in adults: treatment and management
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Starin (Sertraline) (FAQ)

Q: Is Starin (Sertraline) the same as other medications like Prozac or Lexapro?

Starin (Sertraline), Prozac (fluoxetine), and Lexapro (escitalopram) all belong to the same drug category: Selective Serotonin Reuptake Inhibitors (SSRIs). Official sources indicate they share the same core mechanism of affecting serotonin levels. However, they are distinct chemical compounds reviewed for specific indications.

Q: What kinds of food or drinks should be avoided while taking Starin (Sertraline)?

Official product information advises that alcohol and the herbal product St. John’s Wort should be avoided during treatment due to potential negative interactions. Regulatory warnings also note that grapefruit and grapefruit juice can interfere with the metabolism of Starin, potentially leading to increased drug levels. Official advice should be followed.

Q: Are there any common over-the-counter medications that interact with Starin (Sertraline)?

Caution is advised regarding certain over-the-counter medicines. Specifically, when taken with drugs like Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, or aspirin, there is an officially documented increased risk of bleeding. This is due to Starin's documented effect on blood clotting.

Q: Can Starin (Sertraline) be taken during pregnancy?

Official documents note that use during the third trimester may be associated with increased risks, including persistent pulmonary hypertension and withdrawal symptoms in the newborn. Furthermore, the Starin Oral Solution is contraindicated for pregnant patients because it contains alcohol. The decision regarding use during pregnancy should be based on medical guidance.

Q: Is it safe to breastfeed while taking Starin (Sertraline)?

Official literature and reviewers indicate that Starin is a commonly assessed option for use during breastfeeding due to the typically low amounts of the drug found in breast milk. Minimal exposure to the infant is generally expected. However, careful consideration is advised for premature or very young infants.

Q: What is Serotonin Syndrome and how is it related to Starin (Sertraline)?

Serotonin Syndrome (SS) is a serious condition reported in official documents that can occur when Starin is used. Symptoms can include changes in a person's mental status, rapid changes in heart rate or blood pressure (autonomic instability), and problems with muscle control. The risk of Serotonin Syndrome is documented to increase when Starin is used concomitantly with other serotonergic agents.

Q: Why do doctors recommend gradually stopping Starin (Sertraline)?

Regulatory guidance advises a gradual reduction in dosage when discontinuing Starin treatment. This gradual dose reduction is documented as necessary to minimize the risk of developing discontinuation syndrome, which includes symptoms like agitation, dizziness, and strange sensory feelings if the medication is stopped too quickly.

Q: Is Starin (Sertraline) safe for older adults to take?

Official information indicates that use in older adults requires caution and monitoring. This population has a noted increased risk for developing a specific condition called hyponatremia (low sodium levels in the blood). Because of this and other potential risks, the dosage may require careful adjustment and monitoring.

Q: Can men and women experience different side effects from Starin (Sertraline)?

Yes, official regulatory documents list specific side effects based on gender. For example, ejaculation failure is listed as a very common adverse reaction reported specifically in men. Decreased libido is a common side effect reported in both men and women.

Q: What happens if Starin (Sertraline) is taken with a strong pain reliever?

If Starin is combined with pain relievers that are also serotonergic agents (like Tramadol), regulatory warnings state the risk of Serotonin Syndrome is increased. Additionally, using Starin with NSAID pain relievers (like ibuprofen) increases the officially documented risk of abnormal bleeding due to combined effects on blood clotting.

Q: Are studies available on the long-term effects of Starin (Sertraline)?

Official approval is based on clinical trials, and some studies, particularly those focused on preventing the return of depression, have examined treatment over extended durations (e.g., 52 weeks or more). The safety and efficacy over long-term use are considered in the regulatory review process, but specific long-term data for every effect may vary.

Q: Is it normal to feel worse when first starting Starin (Sertraline)?

Official product information notes that symptoms such as anxiety, agitation, panic attacks, or irritability may occur or intensify, particularly during the initial phase of therapy or after a change in dose. Patients should be closely monitored for any significant change in mental status during this time.

Q: Does Starin (Sertraline) cause weight gain?

Regulatory documents list changes in body weight as possible adverse events associated with Starin. Official adverse event listings show that both increased weight and decreased weight (or anorexia) have been reported by patients taking the medication.

Q: Is Starin (Sertraline) considered a controlled substance?

No, Starin (Sertraline) is not classified as a controlled substance by major government drug enforcement bodies. This indicates that official regulatory review determined the drug has little to no risk of abuse or misuse, unlike certain sedatives or opioids.

Q: What are the main risks associated with stopping Starin (Sertraline) suddenly?

One of the key risks of abrupt discontinuation, as noted in official warnings, is the potential for developing discontinuation symptoms. These symptoms can be unpleasant and may include changes in mood, agitation, dizziness, and sensory disturbances (like tingling or electric shock sensations).

Q: Does Starin (Sertraline) cause long-term side effects?

Some official reports indicate that certain adverse effects, such as sexual dysfunction, weight change, and hyponatremia (in the elderly), may persist during long-term treatment. It is generally advised that patients discuss any persistent or new side effects with their healthcare provider during routine checkups.

Q: Does Starin (Sertraline) cause dependency or addiction?

Starin is not classified as a controlled substance and is not considered an addictive drug. The physical symptoms that can occur upon abruptly stopping the medication are a form of physical dependence known as discontinuation syndrome, which is documented as distinct from drug-seeking addiction.

Q: How does Starin (Sertraline) affect driving or operating machinery?

Official information advises caution because Starin is a psychotropic drug that may impair the mental or physical abilities needed to perform tasks requiring vigilance. Regulatory guidance advises caution, and patients are generally advised to observe their reaction to the medication before engaging in such activities.

Q: Does Starin (Sertraline) need to be taken at the same time every day?

Official dosing instructions state that Starin should be administered orally once daily. Taking a once-daily drug consistently at the same time is generally recommended to help maintain consistent drug levels in the bloodstream, according to administration principles.

Q: Can Starin (Sertraline) cause changes in mood or personality?

Regulatory warnings indicate that Starin can affect mood and behavior. It has the potential to trigger mania or hypomania (periods of abnormally elevated mood) in susceptible individuals. Furthermore, patients beginning treatment may experience new or worsening symptoms of anxiety, agitation, or irritability.

Q: Is there a generic version of Starin (Sertraline) available?

Yes, Starin is a brand name. The active ingredient, sertraline hydrochloride, is approved and widely available as a generic medication. Generic versions contain the same active ingredient and are reviewed by regulatory bodies to ensure they meet the same standards as the brand name drug.

Q: Is there a link between Starin (Sertraline) and vision changes?

Yes, official adverse event reports list blurred vision and decreased vision as possible side effects. Furthermore, a specific warning exists that SSRIs like Starin can potentially trigger a serious condition called angle-closure glaucoma in individuals who are susceptible to it.

Q: What is the expected timeline for a review of Starin (Sertraline) treatment?

Official regulatory guidance emphasizes that all patients, especially younger adults, require close clinical monitoring for signs of worsening symptoms or suicidal thoughts. This monitoring is especially important during the initial few months of therapy or immediately following any change in the dosage.

Q: Does Starin (Sertraline) affect cholesterol levels?

Yes, official adverse event reports list changes in cholesterol levels as a possible, though less common, adverse reaction. Specifically, regulatory documentation includes reports of hypercholesterolemia (high cholesterol) in patients taking the medication.

Q: Do different strengths of Starin (Sertraline) tablets have different side effect profiles?

Adverse event profiles are generally based on pooled data across various doses studied in clinical trials. However, official information does state that some rare but serious side effects, such as QT prolongation (a change in heart rhythm), are known to be dose-dependent, meaning the risk may increase with higher doses.

Q: Is Starin (Sertraline) known to interact with grapefruit juice?

Yes, official warnings indicate that Starin (Sertraline) can interact with grapefruit and grapefruit juice. Official warnings state that consuming them can interfere with the metabolism of Starin, potentially leading to increased concentrations of the drug in the bloodstream and an elevated risk of side effects.

Advertisements

How should Starin (Sertraline) be stored and disposed of?

Storage and Disposal Requirements

Sertraline must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original container with the cap tightly closed and protected from excess heat and moisture; therefore, it should not be stored in a bathroom.

All forms of sertraline must be stored out of the sight and reach of children to prevent accidental ingestion. For the oral concentrate solution, any unused portion must be discarded after 4 weeks following the bottle's initial opening.

For disposal, unused or expired sertraline should be returned to a drug take-back location or through a mail-back program. If a take-back option is unavailable, the product is disposed of by mixing it with an undesirable substance (such as dirt or used coffee grounds) in a sealed bag and throwing it in the household trash; sertraline is not recommended for flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Starin (Sertraline) found in:

A-Z Index: